Back to History Current Version

Beyond the Facts: Information, Persuasion, and Belief Change

Last registered on March 06, 2026

Pre-Trial

Trial Information

General Information

Title
Beyond the Facts: Who Changes Minds—Professors or Influencers?
RCT ID
AEARCTR-0016954
Initial registration date
October 07, 2025

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
October 13, 2025, 9:57 AM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Last updated
March 06, 2026, 7:04 AM EST

Last updated is the most recent time when changes to the trial's registration were published.

Locations

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Primary Investigator

Affiliation
Monash University

Other Primary Investigator(s)

PI Affiliation
Monash University
PI Affiliation
Monash University
PI Affiliation
Athens University of Economics and Business

Additional Trial Information

Status
In development
Start date
2025-11-16
End date
2026-06-01
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
Abstract
Vaccination rates are declining globally, threatening public health and herd immunity. Effective communication is critical to counter misinformation and increase vaccine uptake, but little is known about whether messenger identity or communication format most influences beliefs and intentions. This study examines how people respond to trusted scientific sources versus popular non-expert voices, and whether immersive or conventional communication channels affect persuasion and information diffusion. By integrating insights from behavioral economics, communication, and social networks, the project aims to identify evidence-based strategies for improving public health messaging and understanding how messages spread through social connections. Findings will have implications for policymakers, public health agencies, and institutions seeking to enhance engagement with credible science.
External Link(s)

Registration Citation

Citation
Dioikitopoulos, Evangelos et al. 2026. "Beyond the Facts: Who Changes Minds—Professors or Influencers?." AEA RCT Registry. March 06. https://doi.org/10.1257/rct.16954-2.0
Experimental Details

Interventions

Intervention(s)
This project investigates how the identity of a communicator and the format of their message influence individuals’ beliefs and intentions regarding vaccination, while ensuring that the informational content itself is identical across conditions.
Intervention Start Date
2025-12-01
Intervention End Date
2026-02-13

Primary Outcomes

Primary Outcomes (end points)
The primary outcomes capture participants’ beliefs and attitudes toward vaccination and public health institutions following exposure to the informational intervention. The main endpoints are summary indices constructed from post-treatment survey responses:

Trust in Vaccines Index

Trust in Healthcare System / Health Authorities Index

Vaccination Acceptance / Vaccination Intent

These outcomes measure the extent to which exposure to the informational message affects participants’ trust in vaccination, trust in medical institutions, and willingness to accept vaccination recommendations.

Each index will also be analyzed through its individual components as secondary specifications.
Primary Outcomes (explanation)
Trust in Vaccines Index

This index captures participants' beliefs about the effectiveness, safety, and importance of vaccines. It is constructed using responses to the following four items measured on a 0–10 scale:

"Vaccines are effective at preventing pandemics and serious diseases."

"Vaccines are safe for human health."

"Vaccines are important for your own health."

"Vaccines are important for public health."

Trust in Healthcare System Index

This index measures trust in institutions responsible for health and medical care. It is constructed using 0–10 trust questions on:

"conventional medicine and surgery,"

"doctors and healthcare professionals,"

"public health authorities."

The main specification constructs a standardized index using principal component analysis (PCA) applied to these items. The first principal component will be used as the index. The PCA weights will be estimated using the full sample of post-treatment responses. We will also present results by the individual variables.


Vaccination Intent and Vaccination Status (Follow-up Survey)

The follow-up survey includes two measures related to vaccination behavior:

Willingness to vaccinate, capturing participants' stated intention to receive a vaccine.

Vaccination status, indicating whether the participant reports having received the vaccine.

Both variables are coded as as a binary indicator equal to one if the participant reports being more willing to vaccinate or having been vaccinated.

These outcomes allow us to examine whether exposure to the intervention affects both stated vaccination intentions and realized vaccination behavior at follow-up.

Secondary Outcomes

Secondary Outcomes (end points)
Secondary outcomes measure mechanisms through which the intervention may affect attitudes toward vaccination, as well as additional behavioral and evaluative responses to the informational message.

The main secondary outcomes include:

Willingness to discuss vaccination

Perceived credibility and evaluation of the speaker

Engagement and visual attention during the message (VR condition)

These outcomes help identify the channels through which communication medium and speaker identity influence beliefs and attitudes toward vaccination.
Secondary Outcomes (explanation)
Willingness to Discuss with Others (Family and Friends)

This outcome captures whether the intervention changes participants' willingness to discuss different issues with others. It is measured immediately after the intervention using 0–10 scales, where higher values indicate greater willingness to discuss the topic with others (family and friends). The post-treatment survey includes the following items:

willingness to discuss vaccines;

willingness to discuss the healthcare system;

willingness to discuss social media;

willingness to discuss artificial intelligence;

willingness to discuss politics.

The main secondary outcome in this family is willingness to discuss vaccines. The other items serve as comparison or placebo discussion topics and allow us to assess whether treatment effects are specific to vaccination or extend to other domains.


Evaluation of the Speaker and of the Message

These outcomes capture participants' overall impressions of both the messenger and the informational content. They are measured immediately after exposure using a scale from -5 to 5, where higher values indicate a more positive impression. The post-treatment survey includes the following two items:

overall impression of the speaker;

overall impression of the message.

These variables are analyzed separately and capture whether the intervention changes participants' general evaluation of the person delivering the information and of the public health message itself.

Speaker Evaluation and Credibility

These outcomes capture how participants perceive the messenger delivering the public health message. They are measured immediately after exposure using 0–10 scales, where higher values indicate a more favorable evaluation of the speaker. Participants evaluate the speaker along the following dimensions:

charismatic;

persuasive;

reliable;

knowledgeable;

nice;

attractive;

passionate.

In addition to analyzing each item separately, we will construct a Perceived Speaker Quality Index using principal component analysis (PCA). The index will correspond to the first principal component of these seven items.


Visual Attention and Engagement (VR Condition)

For participants assigned to the VR condition, the study records behavioral engagement measures using the eye-tracking capabilities of the VR headset. These measures capture visual attention and engagement during exposure to the message. In particular, we will use indicators such as:

the share of time the participant's gaze is directed toward the speaker during the VR experience;

related gaze-based engagement indicators recorded by the device.

These measures are available only for participants in the VR condition and are used to study mechanisms related to attention and immersion during the informational exposure

Experimental Design

Experimental Design
The study randomly assigns participants to receive identical informational content delivered by either a scientific expert or a popular non-expert communicator. This design allows us to compare the influence of messenger identity on beliefs, attitudes, and intentions, without revealing the specific delivery methods or materials.
Experimental Design Details
Not available
Randomization Method
Each session will be randomly assigned to one treatment arm. All participants to a session will receive the same treatment. Within session, those participating to those sessions receiving the information treatment (either VR or Video) will be randomized into one of the 4 speakers: Male Scientist, Female Scientis, Male Influencer, Female Influencer.
Randomization Unit
Experimental sessions, as each session will see the participants receiving the same treatment.
Was the treatment clustered?
Yes

Experiment Characteristics

Sample size: planned number of clusters
Randomization occurs at the individual participant level. The study therefore does not involve clustered assignment. The planned sample is approximately 1,000 individual participants (clusters of size 1).
Sample size: planned number of observations
The planned number of observations is 1,000, although we will try to collect more based on funding availability.
Sample size (or number of clusters) by treatment arms
Approximately 333 participants in Control, 333 participants in Video, and 333 participants in VR. The primary treatment assignment is across three session-level arms: Control, Video, and VR. The presentation materials describe the treatment arms as VR, Video, or Control.
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
Supporting Documents and Materials

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information
IRB

Institutional Review Boards (IRBs)

IRB Name
Monash University Human Research Ethics Committee
IRB Approval Date
2025-09-19
IRB Approval Number
49408